$KPTI Talk on Wall Street is that one of the following companies will be the lucky one to buy out Karyopharm (KPTI). Which one will win Karyopharm's heart / life-saving safe drug? In a series of posts I will tag one of these companies at a time so its investors could comment. Thank you. Pfizer - PFE - 22 billion cash Bristol Myers Squibb - BMY - 14 billion cash Merck - MRK - 9 billion cash AMGEN - AMGN - 8 billion cash Gilead - $GILD - 7 billion cash Vertex - VRTX - 7 billion cash Takeda - TAK - 6.2 billion cash
5
5
5 Likes